BioFactura Joins Stelara Biosimilar Crowd

US-Based Developer Throws Its Hat Into The Ring For Ustekinumab

 
• By David Wallace
  
Hands Grey Stand Out From The Crowd
Biosimilar ustekinumab developers are part of a growing crowd • Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Biosimilars

More from Products